9 Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Baillière's clinical endocrinology and metabolism

• Publication date

  1990-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0950-351X(05)80084-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals.

  2009cited by this paper
• A new form of coagulation factor VII in plasma.

  2009cited by this paper
• Triglycerides--main lipid risk factor for cardiovascular disease in women?

  2009cited by this paper
• Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid.

  2009cited by this paper
• FACTOR VII-PHOSPHOLIPID COMPLEX IN MALE SURVIVIRS OF ACUTE MYCORDIAL INFARCTION

  2009cited by this paper
• Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.

  1991cited by this paper
• High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients.

  1991cited by this paper
• Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease

  1990cited by this paper
• Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study.

  1990cited by this paper
• Effects of Gemfibrozil on Lipids and Haemostasis after Myocardial Infarction

  1990cited by this paper
• Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.

  1990cited by this paper
• Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.

  1990cited by this paper
• The relevance of a protein-enriched low density lipoprotein as a risk for coronary heart disease in relation to other known risk factors.

  1989cited by this paper
• Plasma Plasminogen Activator Inhibitor‐1 in Angina Pectoris: Influence of Plasma Insulin and Acute‐phase Response

  1989cited by this paper
• Factor VII coagulant activity is strongly associated with the plasma concentration of large lipoprotein particles in middle-aged men.

  1989cited by this paper
• Apolipoprotein, Low Density Lipoprotein Subtraction, and Insulin Associations with Familial Combined Hyperlipidemia: Study of Utah Patients with Familial Dyslipidemic Hypertension

  1989cited by this paper
• Coagulation Factor VII and Plasma Triglycerides

  1989cited by this paper
• Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond.

  1989cited by this paper
• Plasminogen Activator Inhibitor 1: Biosynthesis and mRNA Level Are Increased by Insulin in Cultured Human Hepatocytes

  1989cited by this paper
• Plasma triglyceride levels and coronary disease.

  1989cited by this paper
• Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.

  1989cited by this paper
• Relationships between LDL density and kinetic heterogeneity in subjects with normolipidemia and familial combined hyperlipidemia using density gradient ultracentrifugation.

  1989cited by this paper
• Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals.

  1989cited by this paper
• Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance.

  1989cited by this paper
• Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation.

  1988cited by this paper
• Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal.

  1988cited by this paper
• Role of Insulin Resistance in Human Disease

  1988cited by this paper
• High prevalence of hypertriglyceridaemia and apolipoprotein abnormalities in coronary artery disease.

  1988cited by this paper
• Hyperinsulinemia Is Characterized by Jointly Disturbed Plasma VLDL, LDL, and HDL Levels: A Population‐Based Study

  1988cited by this paper
• Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.

  1988cited by this paper
• Epidemiologic Associations Between Hypertriglyceridemia and Coronary Heart Disease

  1988cited by this paper
• Further resolution and comparison of the heterogeneity of plasma low-density lipoproteins in human hyperlipoproteinemias: type III hyperlipoproteinemia, hypertriglyceridemia and familial hypercholesterolemia.

  1988cited by this paper
• Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study.

  1988cited by this paper
• Low-density lipoprotein subclass patterns and risk of myocardial infarction.

  1988cited by this paper
• Insulin Stimulates the Synthesis of Plasminogen Activator Inhibitor 1 by the Human Hepatocellular Cell Line Hep G2

  1988cited by this paper
• Factor VII activity state in coronary artery disease.

  1988cited by this paper
• Postprandial plasma lipoprotein changes in human subjects of different ages.

  1988cited by this paper
• Distinct murine macrophage receptor pathway for human triglyceride-rich lipoproteins.

  1988cited by this paper
• 9 Hormones and lipoprotein metabolism

  1987cited by this paper
• Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects.

  1987cited by this paper
• High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

  1987cited by this paper
• Metabolic determinants of plasma high-density lipoprotein concentration in humans.

  1987cited by this paper
• Insulin and atheroma--an update.

  1987cited by this paper
• Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations.

  1987cited by this paper
• Body Mass, Blood Pressure, Glucose, and Lipids: Does Plasma Insulin Explain Their Relationships?

  1987cited by this paper
• Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil.

  1987cited by this paper
• The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease.

  1987cited by this paper
• Metformin Decreases the High Plasminogen Activator Inhibition Capacity, Plasma Insulin and Triglyceride Levels in Non-Diabetic Obese Subjects

  1987cited by this paper
• Effect of Gender, Age, and Lipid Status on Low Density Lipoprotein Su bf raction Distribution: Results from the Framingham Offspring Study

  1987cited by this paper
• Relationships Between Plasma Lipoprotein Concentrations and Insulin Action in an Obese Hyperinsulinemic Population

  1987cited by this paper
• Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.

  1987cited by this paper
• Hypolipidemic therapy modulates expression of apolipoprotein B epitopes on low density lipoproteins. Studies in mild to moderate hypertriglyceridemic patients.

  1987cited by this paper
• Increased factor VII coagulant activity in the rabbit following diet-induced hypercholesterolaemia. Evidence for increased conversion of VII to alpha VIIa and higher flux within the coagulation pathway.

  1987cited by this paper
• Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men.

  1987cited by this paper
• Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype.

  1987cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Characterization of high density lipoprotein subspecies: structural studies by single vertical spin ultracentrifugation and immunoaffinity chromatography.

  1987cited by this paper
• Metabolic heterogeneity in very low-density lipoproteins.

  1987cited by this paper
• Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

  1987cited by this paper
• The triglyceride issue: a view from Framingham.

  1986cited by this paper
• Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

  1986cited by this paper
• Conversion of human plasma high density lipoprotein-2 to high density lipoprotein-3. Roles of neutral lipid exchange and triglyceride lipases.

  1986cited by this paper
• Association between dietary fat intake and plasma factor VII coagulant activity--a predictor of cardiovascular mortality.

  1986cited by this paper
• Serum lipoproteins and apolipoproteins in young male survivors of myocardial infarction

  1986cited by this paper
• Haemostatic function in myocardial infarction.

  1986cited by this paper
• The role of hepatic triglyceride lipase in the metabolism of intermediate-density lipoprotein--postheparin lipolytic activities determined by a sensitive, nonradioisotopic method in hyperlipidemic patients and normals.

  1986cited by this paper
• Role of triglyceride-rich lipoproteins and hepatic lipase in determining the particle size and composition of high density lipoproteins.

  1986cited by this paper
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.

  1986cited by this paper
• Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study.

  1986cited by this paper
• Kinetic Heterogeneity of Low Density Lipoproteins in Primary Hypertriglyceridemia

  1986cited by this paper
• Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

  1986cited by this paper
• Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

  1986cited by this paper
• Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.

  1986cited by this paper
• Enrichment of apolipoprotein B-48 in the LDL density class following in vivo inhibition of hepatic lipase.

  1986cited by this paper
• Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells

  1986cited by this paper
• Mechanisms of enhanced cholesteryl ester transfer from high density lipoproteins to apolipoprotein B-containing lipoproteins during alimentary lipemia.

  1986cited by this paper
• High density lipoproteins in postprandial lipemia. Relation to sex and lipoprotein lipase activity.

  1986cited by this paper
• Presence of Multiple Subpopulations of Lipoproteins of Intermediate Density in Normal Subjects

  1986cited by this paper
• Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.

  1985cited by this paper
• Lipoprotein predictors of the severity of coronary artery disease in men and women.

  1985cited by this paper
• Studies of low density lipoprotein molecular weight in human beings with coronary artery disease.

  1985cited by this paper
• Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

  1985cited by this paper
• Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.

  1985cited by this paper
• Low density lipoprotein metabolism in hypertriglyceridemic and normolipidemic patients with coronary heart disease.

  1985cited by this paper
• Modulation of apolipoprotein B antigenic determinants in human low density lipoprotein subclasses.

  1985cited by this paper
• Preferential enrichment of large-sized very low density lipoprotein populations with transferred cholesteryl esters.

  1985cited by this paper
• Defective metabolism of hypertriglyceridemic low density lipoprotein in cultured human skin fibroblasts. Normalization with bezafibrate therapy.

  1985cited by this paper
• General practitioner and long term care of patients with a spinal injury.

  1985cited by this paper
• Generation in plasma of a fast-acting inhibitor of plasminogen activator in response to endotoxin stimulation.

  1985cited by this paper
• Effects of postprandial lipemia on plasma cholesterol metabolism.

  1985cited by this paper
• Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

  1985cited by this paper
• Plasminogen activator inhibitor in the blood of patients with coronary artery disease.

  1985cited by this paper
• Particle size distribution of high density lipoproteins as a function of plasma triglyceride concentration in human subjects.

  1985cited by this paper
• A novel form of factor VII in plasma from men at risk for cardiovascular disease

  1985cited by this paper
• Receptor-mediated uptake of remnant lipoproteins by cholesterol-loaded human monocyte-macrophages.

  1985cited by this paper
• Clinical significance of measurements of serum apolipoprotein A-I, A-II and B in hypertriglyceridemic male patients with and without coronary artery disease.

  1985cited by this paper
• Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

  1985cited by this paper
• Role of lipid transfers in the formation of a subpopulation of small high density lipoproteins.

  1985cited by this paper
• Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study.

  1985cited by this paper
• Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects.

  1984cited by this paper

• Triglyceride-Rich Lipoproteins.

  2018cites this paper
• A CLINICAL STUDY ON ASSOCIATION OF METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PSORIASIS

  2016cites this paper
• Lipid Peroxidation and Total Cholesterol in HAART-Naïve Patients Infected with Circulating Recombinant Forms of Human Immunodeficiency Virus Type-1 in Cameroon

  2013cites this paper
• Diferenças no perfil lipídico dos doentes com AVC isquémico, segundo o subtipo etiológico

  2009cites this paper
• Psoriasis is associated with lipid abnormalities at the onset of skin disease.

  2006cites this paper
• The lipid and lipoprotein profiles of apo B-carrying particles in remnant-like lipoproteins isolated from plasma in sudden cardiac death cases.

  2006cites this paper
• Dossier: Hypertension and cardiovascular diseases: the rational approach Effects of nifedipine, verapamil and diltiazem on serum biochemical parameters and aortic composition of atherosclerotic chickens

  2005cites this paper
• Validity of plasma remnant lipoproteins as surrogate markers of antemortem level in cases of sudden coronary death.

  2004cites this paper
• The Significance of Measuring Non-HDL-Cholesterol

  2002cites this paper
• On the atherogenicity of triglyceride-rich lipoproteins and novel markers for the assessment of their atherogenic potentials

  2002cites this paper
• The influence of skeletal muscle properties, physical activity and physical fitness on serum lipids and the risk of coronary heart disease

  2001cites this paper
• Invited Review: Lipoprotein Lipase and Triglyceride-Rich Lipoprotein Metabolism

  2001cites this paper
• Treatment of mixed hyperlipidaemia using a combination of omega-3 fatty acids and HMG CoA reductase inhibitor

  2001cites this paper
• Association of plasma triglyceride-rich lipoprotein remnants with coronary atherosclerosis in cases of sudden cardiac death.

  1999cites this paper
• Lipid-lowering drugs in the management of hyperlipidaemia.

  1998cites this paper
• Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy.

  1998cites this paper
• Plasma triglycerides and the clinician: time for reassessment.

  1998cites this paper
• The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.

  1997cites this paper
• Postprandial lipoprotein metabolism in normotriglyceridemic non-insulin-dependent diabetic patients: influence of apolipoprotein E polymorphism.

  1996cites this paper
• Hemostatic risk factors for cardiovascular disease

  1996cites this paper
• Climacteric symptoms and control of the cycle in women aged 35 years or older taking an oral contraceptive with 0.150 mg desogestrel and 0.020 mg ethinylestradiol.

  1995cites this paper
• Restriction fragment length polymorphisms at the apoprotein genes AI, CIII and B‐100 and in the 5‘ flanking region of the insulin gene as possible markers of coronary heart disease

  1995cites this paper
• Effects of fish oil on some parameters of fibrinolysis and lipoprotein(a) in healthy subjects.

  1994cites this paper
• The triglyceride issue revisited. Findings from the Helsinki Heart Study.

  1994cites this paper
• Activation of coagulation factor VII during alimentary lipemia.

  1994cites this paper
• n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes.

  1994cites this paper
• Lipoprotein metabolism and renal failure.

  1993cites this paper
• The hemostatic system and coronary heart disease.

  1993cites this paper
• Effects of Fish Oil on Risk Factors for Cardiovascular Disease

  1993cites this paper
• Relationship between plasma plasminogen activator inhibitor-1 activity and VLDL triglyceride concentration, insulin levels and insulin sensitivity: studies in randomly selected normo- and hypertriglyceridaemic men

  1993cites this paper
• Expression of apolipoprotein B epitopes in low density lipoproteins of hemodialyzed patients.

  1993cites this paper
• Electron impact mass spectra of phosphine sulphides and selenides

  1993cites this paper
• Myocardial infarction at a young age: mechanisms and management

  1991cites this paper